par Green, M D;Koelbl, H;Baselga, J;Galid, A;Guillem, V;Gascon, P;Siena, S;Lalisang, R I;Samonigg, H;Clemens, Michael;Zani, V;Liang, B C;Renwick, Jennifer;Piccart-Gebhart, Martine ;International Pegfilgrastim 749 Study Group,
Référence Annals of oncology, 14, 1, page (29-35)
Publication Publié, 2003-01
Référence Annals of oncology, 14, 1, page (29-35)
Publication Publié, 2003-01
Article révisé par les pairs
Titre: |
|
Auteur: | Green, M D; Koelbl, H; Baselga, J; Galid, A; Guillem, V; Gascon, P; Siena, S; Lalisang, R I; Samonigg, H; Clemens, Michael; Zani, V; Liang, B C; Renwick, Jennifer; Piccart-Gebhart, Martine; International Pegfilgrastim 749 Study Group, |
Informations sur la publication: | Annals of oncology, 14, 1, page (29-35) |
Statut de publication: | Publié, 2003-01 |
Sujet CREF: | Sciences bio-médicales et agricoles |
MeSH keywords: | Adult |
Aged | |
Antineoplastic Combined Chemotherapy Protocols -- adverse effects | |
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use | |
Breast Neoplasms -- drug therapy | |
Breast Neoplasms -- pathology | |
Delayed-Action Preparations | |
Double-Blind Method | |
Doxorubicin -- administration & dosage | |
Doxorubicin -- adverse effects | |
Drug Administration Schedule | |
Female | |
Filgrastim -- administration & dosage | |
Filgrastim -- analogs & derivatives | |
Humans | |
Middle Aged | |
Neoplasm Staging | |
Neutropenia -- chemically induced | |
Neutropenia -- drug therapy | |
Neutrophils -- physiology | |
Paclitaxel -- administration & dosage | |
Paclitaxel -- adverse effects | |
Paclitaxel -- analogs & derivatives | |
Taxoids | |
Note générale: | Clinical Trial |
Clinical Trial, Phase III | |
Comment | |
Comparative Study | |
Journal Article | |
Multicenter Study | |
Randomized Controlled Trial | |
Research Support, Non-U.S. Gov't | |
Langue: | Anglais |
Identificateurs: | urn:issn:0923-7534 |
info:pmid/12488289 |